INS and myocarditis: These results indicate that impaired insulin signalling is involved in the mechanism underlying inflammation-induced cardiac dysfunction, at least in part, and implicates a possible application of diabetes medicine for the improvement of insulin resistance in the treatment of myocarditis or DCMi.